Skip to content
Evigrade
CriticalAtypical antipsychotic of the benzamide class×Non-selective beta blocker with class III antiarrhythmic activity

Updated · Methodology

Mechanism

Sotalol, a beta-blocker with class III antiarrhythmic properties, prolongs the QT interval and can cause torsade de pointes. The risk is dose-dependent and rises with a slow heart rate, low potassium or magnesium, and other QT-prolonging drugs (sotalol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The Spanish sotalol SmPC names amisulpride among the antipsychotics that induce torsade de pointes and raise the risk of ventricular arrhythmias when given with sotalol (sotalol SmPC, AEMPS). Amisulpride prolongs the QT interval in a dose- and concentration-dependent way (label of single-dose intravenous amisulpride, US Food and Drug Administration, FDA). The Spanish SmPC for amisulpride tablets lists QT prolongation and torsade de pointes among rare adverse reactions (amisulpride SmPC, AEMPS). Sotalol is not metabolised, and amisulpride is only weakly metabolised. Both are excreted mainly unchanged in the urine, and the level of each rises in renal impairment (sotalol and amisulpride SmPCs, AEMPS). The documents do not describe any effect of one drug on the levels of the other.

Symptoms

QT prolongation itself causes no symptoms and shows only on the electrocardiogram (ECG). Torsade de pointes causes palpitations, dizziness and fainting. It may stop on its own or, rarely, progress to ventricular fibrillation. It usually starts soon after the start of sotalol treatment or a dose increase, but it can also occur after long treatment without a dose change (sotalol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Rare cases of QT prolongation, torsade de pointes, ventricular tachycardia, ventricular fibrillation, cardiac arrest and sudden death have been reported with amisulpride (amisulpride SmPC, AEMPS). Both drugs can slow the heart rate and lower blood pressure, and a slow heart rate itself raises the risk of torsade de pointes (sotalol and amisulpride SmPCs, AEMPS).

Management

The combination is contraindicated. The Spanish sotalol summary of product characteristics (SmPC) contraindicates sotalol with QT-prolonging drugs and names amisulpride both in the contraindications section and in the list of contraindicated combinations (sotalol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The US sotalol label says to avoid use with other QT-prolonging drugs (sotalol label, US Food and Drug Administration, FDA). The Spanish amisulpride SmPC lists sotalol among the QT-prolonging drugs to take into account when combined with amisulpride. It advises caution with amisulpride in known cardiovascular disease or a family history of QT prolongation (amisulpride SmPC, AEMPS). No document states how long to wait when switching from one drug to the other. The half-life of sotalol is 10–20 hours and that of amisulpride about 12 hours (sotalol and amisulpride SmPCs, AEMPS). Withdraw sotalol gradually over one to two weeks, especially in ischaemic heart disease (sotalol SmPC, AEMPS). Gradual withdrawal is also advised for amisulpride (amisulpride SmPC, AEMPS). Start sotalol and increase its dose in a setting where heart rhythm can be monitored. Before that, record an electrocardiogram (ECG) with QT measurement and assess kidney function, electrolytes and all current medicines. Adjust the dose to creatinine clearance and correct low potassium or magnesium before the first dose (sotalol SmPC, AEMPS). If during sotalol treatment QRS or QT lengthens by 25% or more, PQ by 50% or more, or the corrected QT interval (QTc) exceeds 480 ms, reassess benefit and risk and seriously consider a lower dose or withdrawal (sotalol SmPC, AEMPS). Treat torsade de pointes caused by excess sotalol with direct-current (DC) cardioversion, transvenous pacing, adrenaline and/or magnesium sulfate (sotalol SmPC, AEMPS). In amisulpride overdose, continuous cardiac monitoring is recommended (amisulpride SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Amisulpride

Other interactions with Sotalol